The “Reality” Of “Big Pharma” Being Exposed, Worldwide…
From Germany – Opinion By Karma Singh
Following reports to the police by investigative journalists, on Tuesday 17th December 2019, 420 police and six state attorneys began searches of the premises of the pharmaceutical manufacturer, ZytoService in Hamburg as well as 47 other premises, including private houses, medical practises, pharmacies and one hospital.
This concerns the drugs for cancer “therapies” manufactured by ZytoService.
Because of the nature of these drugs, they can only be issued and administered by specialised pharmacies which, of course, creates a monopoly situation. It is this which ZytoService, according to police, used to defraud cancer sufferers in the Hamburg city area of an estimated 8.6 million Euros (approx. $9.5 million) since January 2017.
Many medical doctors received bribes, free “loans” and other expensive kickbacks for prescribing the ZytoService drugs rather than equivalents which are much, much cheaper.
Of course, it wasn’t the patients themselves who paid for the drugs but their medical insurers. As each treatment can cost up to 100,000 Euros ($111,000) this, of course, has an effect upon everyone else’s insurance premiums which, in Germany, are compulsory.
Such cancer treatments are known in the industry as “pharma gold” because an almost monopoly situation enables the unscrupulous to charge prices which may well be many hundreds of times their production costs.
How many of these $111,000 treatments a typical cancer sufferer will receive before they die is, at present, unknown to me. What is very obvious is that the $50,000 reported in my last article as being the typical “fee” per cancer death in 2006 has suffered a case of massive inflation: